| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 05/04/2004 | US6730682 Herpes virus |
| 05/04/2004 | US6730668 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/29/2004 | WO2004035569A2 Novel compounds with antibacterial activity |
| 04/29/2004 | WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | WO2004035536A2 Azo compounds for type i phototherapy |
| 04/29/2004 | WO2004034972A2 Compounds, compositions, and methods |
| 04/29/2004 | WO2004014906A3 Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents |
| 04/29/2004 | WO2003101996A8 Esters in position 20 of camptothecins |
| 04/29/2004 | WO2003099823A3 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2003045919A3 Process for the synthesis of amine ethers from secondary amino oxides and uses |
| 04/29/2004 | WO2003013537A9 Irinotecan for treatment of cancer |
| 04/29/2004 | WO2003013536A9 Methods for treatment of cancer using irinotecan based on ugt1a1 |
| 04/29/2004 | WO2003013535A9 Use of irinotecan for improved treatment of cancer based on mdr1 |
| 04/29/2004 | WO2003013534A9 Methods for the treatment of cancer with irinotecan based on cyp3a5 |
| 04/29/2004 | WO2003013533A9 Methods for improved treatment of cancer with irinotecan based on mrp1 |
| 04/29/2004 | WO2002085909A8 9-deazaguanine derivatives as inhibitors of gsk-3 |
| 04/29/2004 | US20040082785 Process for making an aldehyde |
| 04/29/2004 | US20040082783 Bis (amino acid) molecular scaffolds |
| 04/29/2004 | US20040082742 For addition polymers; using 1-alkoxypiperidine compound |
| 04/29/2004 | US20040082643 Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus |
| 04/29/2004 | US20040082639 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents |
| 04/29/2004 | US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor |
| 04/29/2004 | US20040082611 Novel sulfonyl derivatives |
| 04/29/2004 | US20040082609 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 04/29/2004 | US20040082592 Metabotropic glutamate receptor antagonists |
| 04/29/2004 | US20040082586 Insecticides, nematocides |
| 04/29/2004 | US20040082578 Antiinflammatory agents; Aids therapy; phosphodiesterase inhibitor |
| 04/29/2004 | US20040082575 Compounds and methods for modulation of estrogen receptors |
| 04/29/2004 | US20040082572 Benzodiazepine derivatives as app modulators |
| 04/29/2004 | US20040082565 Formulations and methods of administration of cephalotaxines including homoharringtonine |
| 04/29/2004 | CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | CA2502211A1 Azo compounds for type i phototherapy |
| 04/29/2004 | CA2500320A1 Novel compounds with antibacterial activity |
| 04/28/2004 | EP1412376A2 Compositions and methods for labeling oligonucleotides |
| 04/28/2004 | EP1412361A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 04/28/2004 | EP1411947A2 Salts of substituted 1, 2, 3, 4-tetrahydroisoquinoline-2-carboxylic acid derivatives |
| 04/28/2004 | EP1411881A2 5HT sb 2C /sb RECEPTOR MODULATORS |
| 04/28/2004 | EP0782857B1 use of 4-acylaminopyridine derivatives in the manufacture of a medicament for treating cerebrovascular disorders |
| 04/28/2004 | CN1492869A Tricyclic androgen receptor modulator compounds and method |
| 04/28/2004 | CN1492858A Pylene derivatives and their use as dyes |
| 04/28/2004 | CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 04/28/2004 | CN1492851A Method for synthesizing camptothecin-relating compounds |
| 04/28/2004 | CN1147492C New metal protease inhibitors its preparing method and their medicinal composition containing them |
| 04/28/2004 | CN1147491C Acridine carboxylic ester compound, preparation and medicinal composition thereof |
| 04/28/2004 | CN1147490C Furanotetrapyridine derivatives and its medicinal compounds and their use in the treatment of neurodegenerative disease |
| 04/27/2004 | US6727362 Resistive to concentration quenching; do not change chromaticity |
| 04/27/2004 | US6727257 Hypotensive agents for intraocular pressure; anticholesterol agents; relaxing urinary tract tissue; benign prostatic hyperplasia, impotency, and cardiovascular disorders; antiarrhythmia agents |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727247 Adenosine receptor ligands in a method of treatment, control, or prevention of central nervous system disorders |
| 04/27/2004 | US6726972 Optical data storage medium containing a diaza hemicyanine dye as the light-absorbing compound in the information layer |
| 04/27/2004 | CA2103708C Treatment of ovarian cancer |
| 04/22/2004 | WO2004033461A1 5-SUBSTITUTED 7,9-DIFLUORO-5H-CHROMENO[3,4-f]QUINOLINE COMPOUNDS AS SELECTIVE PROGESTERONE RECEPTOR MODULATORS |
| 04/22/2004 | WO2004033460A1 5-cycloalkenyl 5h-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds |
| 04/22/2004 | WO2004033459A1 5-(1',1'-CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO-5H-CHROMENO[3,4-f]QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS |
| 04/22/2004 | WO2004033451A1 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives |
| 04/22/2004 | WO2004032848A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 04/22/2004 | WO2004032845A2 R-nsaid esters and their use |
| 04/22/2004 | WO2004002986A3 Novel benzimidazole derivatives |
| 04/22/2004 | US20040077879 Building blocks linked together through the formation of rigid diketopiperazine rings |
| 04/22/2004 | US20040077875 (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2 -thiazolyl)carbamic Acid, 1,1-dimethylethyl ester for example; treating immunological and oncological disorders such as inflammatory bowel disease or cancer |
| 04/22/2004 | US20040077703 Nodulisporic acid derivative spot-on formulations for combating parasites |
| 04/22/2004 | US20040077695 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 04/22/2004 | US20040077672 Anticarcinogenic, antiproliferative, and antitumor agents |
| 04/22/2004 | US20040077671 Sorbitol dehydrogenase inhibitors |
| 04/22/2004 | US20040077652 Treating obsessive compulsive disorder, panic attacks, sexual disorders, eating disorders, obesity, drug abuse and ethanol or cocaine dependence; anxiolytic agents |
| 04/22/2004 | US20040077643 3,4 Dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 04/22/2004 | US20040077629 Such as 4-methyl-2-hydroxy-2-(4-hydroxy-4-methylpentyl)-butanediocate ester cephalotaxine derivative |
| 04/22/2004 | US20040077625 Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium codependent bile acid transport abd taurocholate uptake |
| 04/22/2004 | US20040077619 Calcium receptor modulating agents |
| 04/22/2004 | US20040077606 Anticancer, antiangiogenic agents; such as imidazo(1,5-a)-pyrazine-1,3-dione derivatives |
| 04/22/2004 | US20040077605 Cancer, immune disorders; such as 6-hydroxy-4-methyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2-(trifluoromethyl)-benzonitrile |
| 04/22/2004 | US20040077554 Topoisomerase I inhibitors; such as 2,3-methylenedioxy-6-hydroxymethyl-9-hydroxy-12-(beta-D-glucopyranosyl) -6,7,12,13-tetrahydroindolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione |
| 04/22/2004 | US20040077058 Domains of geldanamycin and herbimycin polyketide synthases, polynucleotides that encode such enzymes, and to host cells in which such encoding polynucleotides can be advantageously expressed |
| 04/22/2004 | CA2501834A1 5-substituted 7,9-difluoro-5h-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulators |
| 04/22/2004 | CA2501833A1 5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5h-chromeno[3,4-f]quinolines as selective progesterone receptor modulator compounds |
| 04/22/2004 | CA2501352A1 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives |
| 04/22/2004 | CA2501239A1 R-nsaid esters and their use |
| 04/22/2004 | CA2500758A1 5-cycloalkenyl 5h-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds |
| 04/22/2004 | CA2500582A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 04/21/2004 | EP1411057A1 [3,4-a:3,4-c]carbazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/21/2004 | EP1409490A1 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta a]naphthalenyl derivatives with antipsychotic activity |
| 04/21/2004 | EP1409485A1 Novel immunomodulating compounds |
| 04/21/2004 | EP0964860B1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions |
| 04/21/2004 | CN1491228A Method for purifying 20(S)-camptothecin |
| 04/21/2004 | CN1491225A Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 04/21/2004 | CN1490319A Method for separating high-purity galanthamine from short-tube lycoris crude extract |
| 04/21/2004 | CN1146556C 1,2-dihydroindene or indoline derivatives, preparation and use thereof |
| 04/20/2004 | US6723859 Chromene compound |
| 04/20/2004 | US6723853 Anticancer agents |
| 04/20/2004 | US6723849 Process for making camptothecin derivatives |
| 04/20/2004 | US6723847 3-oxo-n-(5-phenyl-2-pyrimidinyl)spiro(4-azaisobenzofuran-1 (3h),1'-cyclohexane)-4'-carboxamide; neuropeptide y receptor antagonists |
| 04/20/2004 | US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 04/20/2004 | US6723729 Chemical intermediates for anticarcinogenic agent irinotecan |
| 04/20/2004 | CA2256479C Novel photochromic heterocyclic fused indenonaphthopyrans |
| 04/16/2004 | CA2443585A1 New derivatives of (3,4-a:3,4-c) carbazole, their preparation process, and pharmaceutical compositions that contain them |
| 04/15/2004 | WO2004031191A1 Azabicyclic spiroether derivatives as receptor antagonists |
| 04/15/2004 | WO2004031170A1 Method and intermedia used to obtain derivatives of 1-(1h- benzimidazole-2-il)-4-(2-aminopyrimidine)piperidine |
| 04/15/2004 | WO2004031161A1 Neurologically-active compounds |
| 04/15/2004 | WO2004031137A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 04/15/2004 | WO2004030457A1 Nodulisporic acid derivative spot-on formulations for combating parasites |